Literature DB >> 12900351

In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene.

Sandrine Hayette, Isabelle Tigaud, Evelyne Callet-Bauchu, Martine Ffrench, Sophie Gazzo, Kamal Wahbi, Mary Callanan, Pascale Felman, Charles Dumontet, Jean-Pierre Magaud, Ruth Rimokh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12900351     DOI： 10.1182/blood-2003-04-1220

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

Review 1.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

2.  MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

Authors:  Luciano Mazzoccoli; Marcela Cristina Robaina; Alexandre Gustavo Apa; Martin Bonamino; Luciana Wernersbach Pinto; Eduardo Queiroga; Carlos E Bacchi; Claudete Esteves Klumb
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-09       Impact factor: 4.553

3.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells.

Authors:  Chae-Yeon Kim; Keun Na; Saeram Park; Seul-Ki Jeong; Jin-Young Cho; Heon Shin; Min Jung Lee; Gyoonhee Han; Young-Ki Paik
Journal:  Mol Cell Proteomics       Date:  2019-06-17       Impact factor: 5.911

5.  Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.

Authors:  Heike Laman; Juan M Funes; Hongtao Ye; Stephen Henderson; Laura Galinanes-Garcia; Eiji Hara; Phillip Knowles; Neil McDonald; Chris Boshoff
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

6.  CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks.

Authors:  Iris Z Uras; Barbara Maurer; Harini Nivarthi; Philipp Jodl; Karoline Kollmann; Michaela Prchal-Murphy; Jelena D Milosevic Feenstra; Markus Zojer; Sabine Lagger; Reinhard Grausenburger; Beatrice Grabner; Raimund Holly; Anoop Kavirayani; Christoph Bock; Heinz Gisslinger; Peter Valent; Robert Kralovics; Veronika Sexl
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

7.  Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.

Authors:  Dong Chen; Mark E Law; Jason D Theis; Jeffrey D Gamez; Lynn B Caron; Julie A Vrana; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

8.  Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

Authors:  Marc DE Braekeleer; Corine Tous; Nadia Guéganic; Marie-Josée LE Bris; Audrey Basinko; Frédéric Morel; Nathalie Douet-Guilbert
Journal:  Mol Clin Oncol       Date:  2016-02-26

9.  Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.

Authors:  Iris Z Uras; Gina J Walter; Ruth Scheicher; Florian Bellutti; Michaela Prchal-Murphy; Anca S Tigan; Peter Valent; Florian H Heidel; Stefan Kubicek; Claudia Scholl; Stefan Fröhling; Veronika Sexl
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

10.  CDK4: A Key Player in the Cell Cycle, Development, and Cancer.

Authors:  Stacey J Baker; E Premkumar Reddy
Journal:  Genes Cancer       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.